Thank you to the speakers and other participants in WuXi’s global webinar, “Breakthrough Drugs: The Story Behind the Story.”  More than 400 life science innovators tuned in to this webinar to gain insight into the advancement of programs designated by the U.S. Food and Drug Administration as breakthrough therapies.  The breakthrough designation, which enables speedier development and commercialization,  applies to specific drugs that treat serious medical conditions and show signs of  substantial improvements over available  therapies.

The webinar’s elite roster of speakers shared their stories on the discovery and advancement of breakthrough drugs from Pharmasset, Merck, and Pfizer.  These programs had started years before the breakthrough therapy designation was granted, overcoming enormous hurdles with many lessons learned.  The life science community’s enthusiasm for the event highlighted the passion and commitment among companies large and small for developing new therapies that significantly  advance the treatment of serious and life-threatening diseases.

In case you missed the webinar, it is now on demand on the link below.  We welcome  getting you input and feedback in the comments area.


See more information about the webinar Here.

Take post webinar survey Here.

Related links:

Learn more about our International Discovery Service Unit
WuXi Webinar on Neuroscience R&D Drew Over 400 Registrations